pluristem therapeutic (PSTI)

- nasdaq
$3.05 May 17, 2013-03:59 PM ET
Chart_PSTI_365_13.jpg
Chart Type 1D 5D 1M 3M 6M 1Y 2Y 5Y

 

Prev Close: $3.05 Day's Range: $3.0 - $3.06

Open: $3.05 52wk Range: $2.26 - $5.0

P/E Ratio: 0 Volume: 116,712

Beta: 1.35 Avg Vol (3m): 129,375

Div & Yield: Market Cap(Mil.): 179

EPS (ttm): -0.35 P/E (ttm): -8.71


pluristem therapeutic News
  • Pluristem Therapeutics: Preclinical Research Shows PLX Cells May Be Effective In Treating Preeclampsia
    5/13/2013
  • Pluristem Announces New Phase I Trial To Check Safety And Evaluate Effectiveness Of PLX-PAD Cells In Chronic Tendonitis
    5/8/2013
  • Pluristem Identifies First Clinical Indication In Hematology Field For PLX RAD Cells
    5/7/2013
  • Pluristem Expands PLX Product Portfolio In Orthopedics And Sports Medicine
    4/18/2013
  • United Therapeutics Receives Approval To Perform Phase I Study Of Pluristem's PLX-PAD Cells For PAH
    4/11/2013
  • Pluristem Therapeutics Receives FDA Orphan Drug Status Designation For Treatment Of Aplastic Anemia
    2/21/2013

Next 10 Headlines